- Innoviva press release (NASDAQ:INVA): Q2 GAAP EPS of $0.05.
- Revenue of $108.22M (+7.4% Y/Y).
- Royalties increased by 7% to $111.7 million in the second quarter of 2022, compared to the same quarter in 2021
- Entered into definitive merger agreement to acquire all outstanding shares of La Jolla Pharmaceutical Company for $6.23 per share in cash at an implied enterprise value of $149 million in July 2022
Innoviva GAAP EPS of $0.05, revenue of $108.22M
Recommended For You
More Trending News
About INVA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
INVA | - | - |
Innoviva, Inc. |